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a  b  s  t  r  a  c  t
Objective: To check sensitivity and speciﬁcity of assessment instruments of QoL in patients
with  rheumatoid arthritis (RA).
Methodology: Accuracy study in a sample consisting of patients with conﬁrmed diagnosis of
RA.  QoL questionnaires QV SF-36 (Gold Standard), HAQ and NHP were applied. The Pearson
correlation coefﬁcient, ROC curve, AUC and Youden Index (J) were used to analyze the data.
Results: This study enrolled 97 individuals with RA. The functional capacity estimated by
SF-36  was correlated with the total score of HAQ (r = −0.666; p < 0.001; J = 0.579), while the
emotional aspects of SF-36 were correlated with the emotional reactions domain of NHP
(r  = −0.316; p = 0.005; J = 0.341). The vitality domain of SF-36 was correlated with the level
of  energy of NHP (r = −0.362; p = 0.001; J = 0.302). For the evaluation of functional capacity
(AUC = 0.839; p < 0.001) and physical aspect (AUC = 0.755; p < 0.001) the most accurate instru-
ment was the HAQ. For evaluation of the impact of vitality, sleep (AUC = 0.679; p = 0.007),
emotional reactions (AUC = 0.674; p = 0.009) and level of energy in QoL, the NHP (AUC = 0.633;
p  = 0.045) was the most speciﬁc and sensitive. In the evaluation of the emotional aspect
domain, the most accurate instrument was the NHP in the “emotional reaction” score
(AUC = 0.699; p = 0.003). The evaluation of pain was limited in the three instruments and
SF-36 was the only one in assess of the domains of social aspects and general health status.
Conclusion: For evaluation of the physical aspects in patients with RA, the HAQ is the most
accurate. For evaluation of emotional aspects the NHP is the most indicated, although theSF-36 was the only one in the evaluation of general domains.
©  2016 Published by Elsevier Editora Ltda. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Sensibilidade  e  especiﬁcidade  dos  instrumentos  de  avaliac¸ão







r  e  s  u  m  o
Objetivo: Veriﬁcar a sensibilidade e a especiﬁcidade dos instrumentos de avaliac¸ão da qual-
idade de vida em pacientes com artrite reumatoide (AR).
Metodologia: Estudo de acurácia em uma amostra de pacientes com diagnóstico conﬁrmado
de  AR. Aplicaram-se os questionários de QV SF-36 (padrão ouro), HAQ e NHP. Usaram-se
o  coeﬁciente de correlac¸ão de Pearson, a curva ROC, a ASC e o índice de Youden (J) para
analisar os dados.
Resultados: Este estudo envolveu 97 indivíduos com AR. A capacidade funcional esti-
mada pelo SF-36 esteve correlacionada com a pontuac¸ão total do HAQ (r = −0,666; p < 0,001;
J  = 0,579), enquanto o aspecto emocional do SF-36 esteve correlacionado com o domínio
reac¸ão  emocional do NHP (r = −0,316; p = 0,005; J = 0,341). O domínio vitalidade do SF-36
esteve correlacionado com o nível de energia do NHP (r = −0,362; p = 0,001; J = 0,302). Para
a  avaliac¸ão da capacidade funcional (ASC = 0,839; p < 0,001) e aspecto físico (ASC = 0,755;
p  < 0,001), o instrumento mais preciso foi o HAQ. Para a avaliac¸ão do impacto da vitali-
dade,  do sono (ASC = 0,679; p = 0,007), da reac¸ão emocional (ASC = 0,674; p = 0,009) e do nível
de  energia na QV, o NHP (ASC = 0,633; p = 0,045) foi o instrumento mais especíﬁco e sen-
sível. Na avaliac¸ão do domínio aspecto emocional, o instrumento mais preciso foi o NHP no
domínio reac¸ão emocional (ASC = 0,699; p = 0,003). A avaliac¸ão da dor foi limitada nos três
instrumentos e o SF-36 foi o único a avaliar os domínios aspecto social e estado geral de
Saúde.
Conclusão: Para a avaliac¸ão do aspecto físico em pacientes com AR, o HAQ é o instrumento
mais  preciso. Para a avaliac¸ão do aspecto emocional, o NHP é o mais indicado, embora o
SF-36 seja o único a avaliar domínios gerais.




























heumatoid arthritis is an autoimmune disease, of unknown
tiology, characterized by symmetrical peripheral polyarthri-
is. This leads to joint deformity and destruction resulting
rom bone and cartilage erosion,1,2 and almost always leads
o functional compromise of the structures involved.3,4 Epi-
emiological studies have estimated the prevalence of RA at
% of the adult population, ranging from 0.4 to 1.9% at world
evel, and from 0.5 to 1.0% in Brazil.5,6 RA affects three times
s many  women as men, with the highest incidence between
he ages of 30 and 50 years.7,8
The majority of patients will have their independence
ffected to variable degrees, and take ill at a productive age,
hus generating limitations on social, leisure and professional
ctivities.1,9–11 The main symptoms of patients with RA are
ntense pain and functional limitation, with signiﬁcant impact
n quality of life (QoL).12–14 The main objectives in the treat-
ent of patients with RA are to prevent or control articular
esions, prevent the loss of function and diminish pain, in an
ndeavor to improve their quality of life.2
Because this is a chronic disease, the outcome expected
ust not be evaluated by traditional epidemiological meas-
res alone, and therefore, the impact of the disease on QoL has
een adopted to improve outcome measurements.15,16 The
se of speciﬁc tools for this purpose is most valuable17 and
arious instruments have been proposed in order to detect
hanges in the state of health over the course of time, in BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
addition to evaluating the prognosis, risks and beneﬁts of
a certain therapeutic intervention.5 Among the instruments
most used for making this evaluation, the Medical Outcomes
Study, 36-Item Short-Form Health Survey (SF-36), Stanford
Health Assessment Questionnaire (HAQ) and the Nottingham
Health Proﬁle (NHP) are the most outstanding. However, it is
not clear which of these is most recommended for evaluat-
ing the different aspects of QoL in patients who  suffer from
chronic problems resulting from RA.
The SF-36 is a multidimensional, generic questionnaire,
which has been shown to be suited to the socioeconomic
and cultural conditions of the Brazilian population in patients
with RA.18 Because it is the instrument most adopted in stud-
ies at world level by recommendation of the World Health
Organization (WHO), it is considered the Gold Standard in
the evaluation of QoL.19 The NHP is a generic instrument
for evaluation the QoL of persons with different chronic dis-
eases, but it has been widely used in patients with RA.20 The
HAQ is a questionnaire speciﬁcally for RA, with the purpose
of quantifying the impact of the disease on the daily func-
tions of individuals.21,22 It measures the level of difﬁculty the
patient presents in performing activities, as well as the need
for assistance.4,12,23
The use of these questionnaires allows one to understand
the impact of the disease on the individual’s life from his/her
perception, and not only according to structural and func-
tional markers. In spite of the instruments containing closed
questions, they were developed from relevant data related
by persons who suffer from the disease. All the instruments
 o l . 2408  r e v b r a s r e u m a t
generate scores that have been validated and are determi-
nant for the evaluation of QoL.15,21 However, each instrument
evaluates different aspects of QoL and the choice for appli-
cation in clinical practice and observational studies, and for
responses to differences sometimes becomes random. There-
fore, the aim of the present study was to verify the sensitivity
and speciﬁcity of the instruments used in the assessment of
QoL in patients with RA.
Materials  and  methods
The present accuracy study was conducted in individuals
with RA, diagnosed in accordance with the criteria of the
American College of Rheumatology,5 who came from a Ref-
erence Outpatients Clinic for the Treatment of Collagenoses,
in the municipality of Salvador, Bahia, Brazil. Included in
the study were individuals with conﬁrmed diagnosis of RA,
with a moderate or high level of activity of the disease, of
both sexes, and age equal to or over 18 years. Patients were
excluded when they presented limitation in understanding
the research instruments, and so were those who presented
other associated chronic, degenerative, neurological, ortho-
pedic, pneumological and cardiological diseases, with the
potential of being confounding elements.
The patients were contacted by telephone, and data
obtained from the clinical record charts were used. Data
collection was based on primary data, and was performed
in three stages: (1) blood exam; (2) radiographic exam and
(3) application of the questionnaires. The participants were
directed to a private room, where the objectives of the study
and the procedures adopted were explained in a standardized
manner. The ﬁrst two  stages constituted the stage of inclusion
of the volunteers, in order to determine the level of disease
activity. The third stage involved the application of the spe-
ciﬁc instruments. Data was collected in the period between
October 2011 and July 2012.
The research project was approved by the Research Ethics
Committee of the Bahiana School of Medicine and Public
Health, Protocol No. 002/2011 and was conducted in compli-
ance with all the principles deﬁned by Law Decree 196/96 of
the National Health Council with respect to research in human
beings. Subjects who  agreed to participate, signed the Term of
Free and Informed Consent.
To estimate the sample size required to answer the ques-
tion of the investigation, the following parameters were
adopted: standard deviation of 10 for the three curves (HAQ,
SF-36 and NHP), error of the estimate of 2 (considering the min-
imum proximity for the values of the area under the curve) and
alpha of 5%. Using the LEE on-line calculator of USP (available
at http://www.lee.dante.br/cgi-bin/uncgi/calculo amostra) it
was concluded that 96 individuals would be needed. If appli-
cation in 10 individuals were considered for each domain of
the SF-36, which was considered the gold standard, the esti-
mated sample would be 80 participants. Thus the ﬁnal sample
was estimated at 88 individuals (arithmetic mean of 96 and 80).
When calculating a loss of 9 (10%), the sample was increased to
97. From the clinical record chart database of the service, con-
taining 456 registered patients, 97 participants were randomly
selected, using a random number table. When the individual 0 1 6;5 6(5):406–413
was not available on being contacted, or did not wish to par-
ticipate, the next number on the table was included in the list
of participants until the estimated size was attained.
The sociodemographic characteristics of each individual
were evaluated by means of a questionnaire composed of the
following information: sex, age, educational level, smoking,
alcohol consumption, body mass index (BMI), marital status
and socioeconomic class, analyzed by the ABEP criteria of 2008
(Associac¸ão Brasileira de Institutos de Pesquisa de Mercado) –
a Brazilian market research institute that categorizes socio-
economic conditions into eight classes, from “A1 through to
E”, in which Class “A1” represents the highest socioeconomic
level (best housing qualiﬁcation and pattern of consumption)
and “E”, the worst.
Blood was collected to test for the following factors:
rheumatoid factor (RF), C-reactive protein (CRP), erythrocyte
sedimentation rate (ESR), and antinuclear factor (ANF). After
this, the radiologic exam was performed, which includes
radiographs of the wrists and hands for diagnostic conﬁrma-
tion and identiﬁcation of the level of disease activity. Only
patients with a moderate to high level of disease activity were
included, which was evaluated by means of using the DAS-
protocol 28.24
The questionnaires SF-36 (version 2.0), NHP and HAQ were
used to evaluate the QoL. All the instruments were applied
in a uniform manner, by the same researchers, and all the
recommendations of the authors of the instruments were
adopted.18,20,21 Initially, the quality of life dimensions mea-
sured by SF-36 were dichotomized, using the median as cut-off
point. Our a priori hypothesis was that we would ﬁnd positive
correlations between the following domains of the SF-36 and
NHP: physical aspect (SF-36) and physical abilities (NHP); vital-
ity (SF-36) and energy level (NHP); emotional aspects (SF-36)
and emotional reactions (NHP); and social aspect (SF-36) and
social interaction (NHP). We also considered that total HAQ
score would correlate positively with all the domains of SF-36
and NHP.
Correlation analyses were performed by means of the
Pearson linear correlation test and receiver operating char-
acteristic (ROC) curve, area under the curve (AUC) and the
Youden Index, which were used to identify which of the instru-
ments would be most speciﬁc and sensitive for evaluating QoL
in patients with RA. In the Youden Index (J), the best cut-
off point was considered that at which the lowest number of
incorrect diagnoses (false negative plus false positive) were
obtained. The values closest to J = +1 were considered the best
methods for the evaluation of QoL. If the test did not have a
diagnostic value, the index was considered equal to zero (J = 0).
If the values were between 0 and −1 it was considered that
the test was negatively associated with the true diagnosis.25
The data were analyzed using the statistical software package
SPSS, version 21.0, adopting an alpha value of 5% as signiﬁcant,
with the power of the study of 80%.
ResultsThe research participants were 97 individuals, with predomi-
nance of the female sex (92.8%) and mean age of 52.5 ± 11.07
years. The predominant, self-declared skin color was mulatto
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Illiterate (up to 3rd grade) 14 14.4
Up to 4th Grade Primary Schooling 20 20.6
Complete Primary Schooling 19 19.6
Complete High Schooling 34 35.1















47.4%); the social class most frequently cited was C2 (39.2%)
nd the most frequent educational level was complete sec-
ndary education (35.1%) (Table 1). The correlations between
F-36 and the domains of NHP and the total score of HAQ are
ighlighted in Table 2. In order to detect which of the ques-
ionnaires presented the best sensitivity and speciﬁcity, ROC
urves were built (Fig. 1). Data to describe the area under the
urve of each domain NHP and the total score of the HAQ
n comparison with the domains of the SF-36 are shown in
able 3.
Table 2 – Correlation between the domains of the “NHP” and “H






r p r p r p 
Functional capacity −0.58 <0.01 −0.59 <0.01 0.31 <0.01 
Physical aspect −0.40 <0.01 −0.031 <0.01 −0.24 0.02 
Pain 0.07 0.49 0.21 0.06 0.15 0.17 
General health status −0.06 0.57 −0.09 0.42 −0.14 0.20 
Vitality −0.36 <0.01 −0.29 <0.01 −0.39 <0.01 
Social aspect 0.03 0.78 −0.19 0.08 0.12 0.28 
Emotional aspect −0.16 0.15 −0.04 0.68 −0.31 <0.01 
Mental health −0.30 <0.01 −0.32 <0.01 −0.63 <0.01 
NHP, Nottingham Health Proﬁle; HAQ, Stanford Health Assessment Questi 6;5 6(5):406–413 409
The dimension theoretically related to the functional
capacity of SF-36 (Fig. 1A) was the total score of HAQ,
which presented negative correlation in the studied sample
(r = −0.666; p < 0.001) (Table 2). The dimension theoretically
related to the physical aspect (Fig. 1B) of SF-36 was the phys-
ical ability domain of the NHP, which also presented negative
correlation in the studied sample (r = −0.240; p = 0.033). The
dimension theoretically related to the dimension pain (Fig. 1C)
of SF-36 was the pain domain of the NHP, which presented
no correlation with the SF-36 in the studied sample (r = 0.210;
p = 0.063) (Table 2). As was observed in the correlation tests,
none of the variables presented a signiﬁcant area below the
curve. There are no dimensions of HAQ or NHP theoretically
related to the general health status (Fig. 1D) of the SF-36. Sim-
ilarly, in the studied sample, none of the domains of these
scales presented correlation with this domain of SF-36. The
dimension theoretically related to vitality (Fig. 1E) of SF-36 was
the level of energy of the NHP, which presented negative corre-
lation in the studied sample (r = −0.362; p = 0.001) (Table 2). The
dimension theoretically related to the social aspect (Fig. 1F) of
SF-36 was the social interaction domain of the NHP,  which
presented positive correlation in the studied sample (r = 0.305;
p = 0.006), however in the opposite direction to that expected.
The dimension theoretically related to the emotional aspect
(Fig. 1G) of SF-36 was the emotional reactions domain of the
NHP, which presented negative correlation in the studied sam-
ple (r = −0.316; p = 0.005). There are no dimensions of HAQ or
NHP theoretically related to the mental health domain (Fig. 1H)
of the SF-36. However, all the scales of the NHP and the HAQ
total score also presented correlation with the mental health
of the SF-36 in the studied sample (Table 2).
Discussion
This study sought to verify the sensitivity and speciﬁcity of
three of the most used tools in assessing the Quality of Life
in patients with rheumatoid arthritis. Using the SF-36 as the
gold standard, each of its domains was compared with the
HAQ total score and with the different dimensions of the NHP.
The results showed that the relationships expected and con-
ﬁrmed in the analyses were as follows: “functional capacity”





r p r p r p r p
−0.20 0.07 −0.19 0.08 −0.63 <0.01 −0.66 <0.01
−0.07 0.53 −0.19 0.08 −0.24 <0.01 −0.43 <0.01
0.02 0.81 0.07 0.52 −0.05 <0.60 0.02 <0.80
0.22 0.05 0.05 0.65 −0.05 <0.61 −0.14 <0.20
−0.28 0.01 −0.16 0.15 −0.24 <0.03 −0.26 <0.01
−0.15 0.17 0.30 <0.01 0.02 <0.85 −0.05 <0.62
−0.03 0.79 −0.36 <0.01 −0.16 <0.14 −0.18 <0.09
−0.23 0.04 −0.43 <0.01 −0.22 <0.04 −0.34 <0.01
onnaire; SF-36, Short Form-36 item.
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Fig. 1 – Curves ROC for sensibility and speciﬁcity measure of instruments to assess quality of life in rheumatoid arthritis
individuals. (A) Functional capacity domain; (B) physical aspect domain; (C) general health domain; (D) emotional aspect
domain.
with the “HAQ Total Score”; “emotional aspect” with “Emo-
tional Relationships” of the NHP; and “vitality” with the “level
of energy” of the NHP.
Both generic and speciﬁc instruments are important for
studying the health-related aspects of quality of life in
rheumatoid arthritis. Generic instruments, such as the SF-36
and NHP may allow comparison with other groups of individ-
uals, however, they may have low sensitivity to the changes
in follow-up studies.20 Whereas, speciﬁc instruments, such as
the HAQ are more  sensitive to changes in health status, how-
ever, their results may not be compared with the results of
other groups.26
The majority of the sample of this study was made up of
women (9:1) and was similar to the ﬁndings of various studiesthat involved persons with RA in Latin American Countries.4,27
However, it differed from the ﬁndings of American studies,
which revealed a ratio of 3:11,9,28,29 and European, of 2:1.17
The demographic characteristics may have inﬂuenced these
results, as there is still a scarcity of Brazilian results.10,30
Latin American countries present very complex demographic
aspects with a highly miscegenated population, and elevated
diversity of genetic expression.1,27 Women also have less
propensity to attain remission after treatment.10 The mean
age of our patients was similar to that found in other studies
8,14,15,31of populations with RA. The majority of the patients
in this study presented a low socioeconomic and educational
level, which are data compatible with those of the studies of
Corbacho14 and Costa.4 The similarity to populations of other
r e v b r a s r e u m a t o l . 2 0 1
Table 3 – Area under the ROC curve in the domains of





Level of energy 0.786 <0.001
Pain 0.767 <0.001
Emotional reaction 0.671 0.009
Sleep 0.621 0.064
Social interaction 0.604 0.111
Physical abilities 0.771 <0.001
HAQ score 0.839 <0.001
Physical
aspect
Level of energy 0.751 <0.001
Pain 0.699 0.004
Emotional reaction 0.625 0.069
Sleep 0.536 0.598
Social interaction 0.575 0.273
Physical abilities 0.618 0.087
HAQ score 0.755 <0.001
Pain Level of energy 0.493 0.922
Pain 0.365 0.051
Emotional reaction 0.411 0.196
Sleep 0.446 0.435
Social interaction 0.402 0.154
Physical abilities 0.479 0.764
HAQ score 0.476 0.733
Vitality Level of energy 0.633 0.045
Pain 0.612 0.091
Emotional reaction 0.674 0.009
Sleep 0.679 0.007
Social interaction 0.498 0.980
Physical abilities 0.566 0.323
HAQ score 0.583 0.210
Social
aspect
Level of energy 0.477 0.770
Pain 0.576 0.332
Emotional reaction 0.467 0.670
Sleep 0.571 0.359
Social interaction 0.416 0.282
Physical abilities 0.471 0.713
HAQ score 0.531 0.687
Emotional
aspect
Level of energy 0.631 0.048
Pain 0.605 0.113
Emotional reaction 0.699 0.003
Sleep 0.518 0.788
Social interaction 0.675 0.008
Physical abilities 0.628 0.053
HAQ score 0.671 0.010
Mental
health
Level of energy 0.647 0.025
Pain 0.637 0.037
Emotional reaction 0.770 0.001
Sleep 0.631 0.047
Social interaction 0.653 0.020
Physical abilities 0.604 0.113
HAQ score 0.615 0.080




tHealth Proﬁle; ROC, Receiver Operating Characteristic Curve; SF-36,
Short Form-36 item.
tudies points to the possibility of extrapolating the ﬁndings
o other samples.
In this study it was possible to observe that in order to eval-
ate functional capacity, the best instrument was the HAQ
otal score, which presented the largest area under the ROC 6;5 6(5):406–413 411
curve, with elevated sensitivity and speciﬁcity. This result was
expected, since the items of the scale that measures the func-
tional capacity of the HAQ are related to dependence and
functional incapacity, and these patients presented impor-
tant joint damage with loss of function.18,20 In the study of
Ciconelli,18 the signiﬁcant correlations occurred between the
functional component of the F-36 and the aspects of mobility
and pain of the NHP. In the study of Garip,8 the question-
naire Quality of Life in Rheumatoid Arthritis (RAQol) was
compared with the other scales, and it was observed that the
RAQol showed high correlation with the HAQ. The HAQ is a
tool capable of reﬂecting the evolutional condition of the dis-
ease, objectively evaluating the functional state of patients,
and may possibly be useful for following-up the functional
response to treatment.21,32
With regard to the physical aspect domain of the SF-36,
both the physical ability of NHP and the HAQ total score
were shown to be efﬁcient in determining the impact of
physical limitations caused by RA, allowing any of the three
instruments to be used. However, it was the HAQ that pre-
sented the largest area under the curve, and is therefore the
instrument most indicated for this evaluation. In an accu-
racy study using the Cedars-Sinai Health-Related Quality of
Life for Rheumatoid Arthritis Instrument (CSHQ-RA), the SF-
36 and HAQ demonstrated that the items relative to physical
incapacity were strongly correlated with the HAQ and the
physical component of the SF-36.33 Our ﬁndings are in agree-
ment with the results of the study of Garip,8 in which all the
subgroups of the NHP presented high correlation with the
HAQ.
Whereas, in the evaluation of pain, which has speciﬁc
domains in both SF-36 and NHP, it was not possible to verify
any correlation in the sample of this study. The subjectivity
of multiple factors involved in the perception of pain in a
chronic morbidity such as RA may possibly be limiting fac-
tors for the use of these instruments in this evaluation. This
result may also be related to the frequent use of modifying
drugs, analgesics and strict control of inﬂammatory activity
in these patients during the course of the disease, factors that
may inﬂuence this domain.20
It was also not possible to ﬁnd any theoretical basis for
comparison of the general health status of SF-36 with any
scale of the NHP or total score of HAQ. This fact points out
the need for elaboration and development of instruments for
evaluating this domain in populations with RA. This ﬁnding
also suggests that care must be taken when using the total
score of the instruments, since the domains such as these may
inﬂuence the ﬁnal result.
With regard to the vitality aspect of the SF-36, there was
high correlation with the item sleep of the NHP,  followed by
the emotional reaction and level of energy. This ﬁnding may
be related to the fact that in chronic diseases with incapaci-
tating characteristics, highly linked to depression and anxiety,
it is common to ﬁnd associated sleep disturbances.20 Patients
consider the dimensions energy/vitality and sleep important
in the impact on QoL and development of the disease, and
this is an advantage with regard to use of the NHP and SF-36
instruments.26
For the social aspect dimension, inverse correlation with
the social interaction scale of the NHP was veriﬁed, which
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may be inﬂuenced by semantic aspects which deserve more
in-depth studies. In the study for validation of the SF-36 in the
Portuguese language, in patients with RA, higher mean val-
ues were found for the components social aspects and mental
health.18 The domain that evaluates social issues has limita-
tions as regards the validity of the clinical application in both
instruments.20
With regard to the emotional aspect of the SF-36, cor-
relation was found with the emotional reaction scale of
the NHP, and this presented a larger area under the curve.
This result is consistent with the tendency to present
depression and anxiety.1 Lillegraven and Kvien26 revealed
that the emotional aspect and emotional reaction domains
were similar dimensions. A negative correlation was also
observed with the social interaction scale (NHP) and the sec-
ond highest area under the curve, which may clearly be
justiﬁed, because the patient’s emotional state may have
an inﬂuence on his/her social relationships and make it
possible for him/her to have a tendency toward seeking
isolation.20 The three instruments presented good conditions
for evaluating this aspect, however, the NHP was the most
suitable.
With regard to mental health, the variable that presented
the largest area under the curve was emotional reaction (NHP)
and this ﬁnding corroborates the study of Ciconelli,18 which
demonstrated good correlation between the NHP and SF-36 in
this domain.
The results of the present study indicated that many  stud-
ies must still be developed before indiscriminate use is made
of instruments for evaluating the impact on the quality of life
in persons who  suffer damage to their health. Persons affected
by chronic diseases, such as in the case of RA, need to be
constantly followed-up, not only as regards the evolution of
objective clinical parameters, but mainly with regard to the
subject’s perception, involving biopsychosocial aspects of the
health-disease process.
An important limitation of this study was the absence of
a prospective reassessment of participants to estimate sen-
sitivity to change in QoL. This limitation was consequent to
the lack of adherence by the participants, which did not want
to come back to a second assessment with the same instru-
ments.
The main conclusion of this study is that the three instru-
ments most used in the evaluation of the impact on QoL
of the morbidity of RA, validated and available in the Por-
tuguese language of Brazil, namely: SF-36, HAQ and NHP
– are useful and should be applied in clinical studies and
scientiﬁc researches. All of these instruments demonstrated
good sensitivity and speciﬁcity in the major part of the
domains evaluated. However, it is also possible to conclude
that for evaluation of physical and subjective aspects, differ-
ences in accuracy between them may indicate differentiated
choices for their application. For evaluation of the physical
aspects in patients with RA, the HAQ is the most accurate.
For evaluation of emotional aspects the NHP is the most
indicated. SF-36, HAQ and NHP are easy to understand, auto-
applicable and quick to ﬁll (<10 min  each), and may be used
in clinical and research settings. However, the impact of pain
on QoL was not well evaluated by any of the instruments
tested.
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